Literature DB >> 26907222

Negative-dominance phenomenon with genetic variants of the cardiac sodium channel Nav1.5.

Valentin Sottas1, Hugues Abriel2.   

Abstract

During the past two decades, many pathological genetic variants in SCN5A, the gene encoding the pore-forming subunit of the cardiac (monomeric) sodium channel Na(v)1.5, have been described. Negative dominance is a classical genetic concept involving a "poison" mutant peptide that negatively interferes with the co-expressed wild-type protein, thus reducing its cellular function. This phenomenon has been described for genetic variants of multimeric K(+) channels, which mechanisms are well understood. Unexpectedly, several pathologic SCN5A variants that are linked to Brugada syndrome also demonstrate such a dominant-negative (DN) effect. The molecular determinants of these observations, however, are not yet elucidated. This review article summarizes recent findings that describe the mechanisms underlying the DN phenomenon of genetic variants of K(+), Ca(2+), Cl(-) and Na(+) channels, and in particular Brugada syndrome variants of Na(v)1.5. This article is part of a Special Issue entitled: Cardiomyocyte Biology: Integration of Developmental and Environmental Cues in the Heart edited by Marcus Schaub and Hughes Abriel.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26907222     DOI: 10.1016/j.bbamcr.2016.02.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.

Authors:  Marta Pérez-Hernández; Marcos Matamoros; Silvia Alfayate; Paloma Nieto-Marín; Raquel G Utrilla; David Tinaquero; Raquel de Andrés; Teresa Crespo; Daniela Ponce-Balbuena; B Cicero Willis; Eric N Jiménez-Vazquez; Guadalupe Guerrero-Serna; Andre M da Rocha; Katherine Campbell; Todd J Herron; F Javier Díez-Guerra; Juan Tamargo; José Jalife; Ricardo Caballero; Eva Delpón
Journal:  JCI Insight       Date:  2018-09-20

2.  Modeling the Interactions Between Sodium Channels Provides Insight Into the Negative Dominance of Certain Channel Mutations.

Authors:  Echrak Hichri; Zoja Selimi; Jan P Kucera
Journal:  Front Physiol       Date:  2020-11-05       Impact factor: 4.566

Review 3.  Cardiac Arrhythmias as Manifestations of Nanopathies: An Emerging View.

Authors:  Przemysław B Radwański; Christopher N Johnson; Sándor Györke; Rengasayee Veeraraghavan
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

4.  Mutations in NaV1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel.

Authors:  Eyal Nof; Leonid Vysochek; Eshcar Meisel; Elena Burashnikov; Charles Antzelevitch; Jerome Clatot; Roy Beinart; David Luria; Michael Glikson; Shimrit Oz
Journal:  Front Physiol       Date:  2019-06-05       Impact factor: 4.566

5.  Correlation Analyses of Clinical Manifestations and Variant Effects in KCNB1-Related Neurodevelopmental Disorder.

Authors:  Juan Xiong; Zhonghua Liu; Shimeng Chen; Miriam Kessi; Baiyu Chen; Haolin Duan; Xiaolu Deng; Lifen Yang; Jing Peng; Fei Yin
Journal:  Front Pediatr       Date:  2022-01-05       Impact factor: 3.418

6.  Calmodulin binds to the N-terminal domain of the cardiac sodium channel Nav1.5.

Authors:  Zizun Wang; Sarah H Vermij; Valentin Sottas; Anna Shestak; Daniela Ross-Kaschitza; Elena V Zaklyazminskaya; Andy Hudmon; Geoffrey S Pitt; Jean-Sébastien Rougier; Hugues Abriel
Journal:  Channels (Austin)       Date:  2020-12       Impact factor: 2.581

7.  Nav1.5-E3 antibody inhibits cancer progression.

Authors:  Rui Gao; Ting Cao; Hui Chen; Jing Cai; Ming Lei; Zehua Wang
Journal:  Transl Cancer Res       Date:  2019-02       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.